• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » harm reduction

Items Tagged with 'harm reduction'

ARTICLES

E57FF121-5998-4A2D-A5EB-B87A55EEAF55.png
Clinical Update

Overview of Stimulants

October 1, 2024
Michael Weaver, MD, FASAM and Noah Capurso, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Michael Weaver, MD, DFASAM. Professor and Medical Director, Center for Neurobehavioral Research on Addiction at the University of Texas Medical School, Houston, TX.

Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, and Editor-in-Chief, The Carlat Addiction Treatment Report.

Drs. Weaver and Capurso have no financial relationships with companies related to this material.

This article offers an insightful overview of the pharmacology of various stimulant drugs, their potential for misuse, and the dangers they pose—especially with rising overdose rates due to contamination with fentanyl. Learn about the history, various classes of stimulants, and the treatments available for stimulant use disorder, as well as the crucial harm reduction strategies aimed at minimizing risks.


Read More
gavel_AlexStaroseltsev_shutterstock_404793811.jpg
Expert Q&A

Opioid Use Disorder in Correctional Facilities

July 1, 2024
Elizabeth Needham Waddell, PhD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA2-Elizabeth-Needham-Waddell_headshot.jpgElizabeth Needham Waddell, PhD. 

Associate Professor, OHSU-PSU School of Public Health & Section of Addiction Medicine, Division of General Internal Medicine, Oregon Health & Science University, Portland, OR.

Dr. Waddell has no financial relationships with companies related to this material.

People with opioid use disorder who are incarcerated have an elevated rate of morbidity and mortality, particularly following release.


Read More
Clinical Update

Xylazine: An Emerging Threat in the Opioid Overdose Epidemic

October 31, 2023
Roberto Sanchez, MD and Noah Capurso, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Roberto Sanchez, MD. Addiction psychiatry fellow, Yale University School of Medicine, New Haven, CT.

Noah Capurso, MD, MHS. Assistant professor of psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Sanchez and Dr. Capurso have no financial relationships with companies related to this material.

Xylazine is the latest contaminant being found in the American illicit drug supply. A non-opioid itself, xylazine is usually combined with fentanyl, with which it has synergistic sedative effects. Patients using xylazine can have profound levels of sedation and develop severe peripheral wounds. In this article, we discuss xylazine essentials and cover harm reduction strategies to help keep your patients safe.


Read More
CATR_JulAugSept_cover_shutterstock_1572207760.jpg
Expert Q&A

The State of Opioids on the Street

May 29, 2023
Daniel Ciccarone, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA1_headshot_DanielCiccarone.jpgDaniel Ciccarone, MD, MPH. 

Justine Miner Professor of Addiction Medicine at the University of California San Francisco.

Dr. Ciccarone is a member of the scientific advisory board for Celero Systems. Relevant financial relationships listed for the author have been mitigated.

Dr. Ciccarone sheds light on the current chaotic and perilous situation surrounding illicit opioids found on the streets.


Read More
Clinical Update

Fentanyl Testing: An Emerging Harm Reduction Strategy

May 29, 2023
Noah Capurso, MD and Alyssa Falleni, PharmD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Alyssa Falleni, PharmD. CT Health Education and Research in SUD and Related Harms (CHERISH) Fellow; VA Connecticut Healthcare System, Orange, CT.

Noah Capurso, MD, MHS. Assistant Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief of The Carlat Addiction Treatment Report.

Dr. Falleni and Dr. Capurso have no financial relationships with companies related to this material.

Discover the lifesaving potential of fentanyl test strips (FTS). As fentanyl infiltrates illicit drug markets, FTS offer an essential harm reduction strategy. We’ll explore the technology behind FTS, how to obtain and use them, discuss their legality, and examine their role in preventing opioid overdose deaths. 


Read More
Expert Q&A

Substance Use Disorders in Older Adults: A Growing Concern

May 11, 2023
Olivera J. Bogunovic, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA2_OliveraBogunovicHeadshot.jpegOlivera J. Bogunovic, MD.

Medical director of ambulatory services in the Division of Alcohol, Drugs, and Addiction at McLean Hospital, Belmont, MA; assistant professor of psychiatry, Harvard Medical School, Boston, MA.

Dr. Bogunovic has no financial relationships with companies related to this material.

Older adults with substance use disorders present to clinicians in various stages of change. Dr. Bogunovic discusses brief clinical interventions including motivational interviewing and how to approach harm reduction.


Read More
Substance_Use_Sites.jpeg

Supervised Drug Consumption Sites

November 14, 2022
Noah Capurso, MD, MHS and Christopher Clayton, MD, EdM

Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.


Read More

Supervised Drug Consumption

July 1, 2022
Christopher Clayton, MD, EdM and Deepti Anbarasan, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Christopher L. Clayton, MD, EdM. PGY-4 psychiatry resident, NYU Gorssman School of Medicine, New York, NY.

Deepti Anbarasan, MD. Associate Professor in Psychiatry and Neurology, New York University, New York, NY.

Dr. Clayton and Dr. Anbarasan, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Supervised Consumption Sites are clinical settings where patients can use drugs in as safe a manner as possible. Clients are supplied with sterile equipment and the clinics are staffed by medical professionals who can respond in the case of an overdose. Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.


Read More

Supervised Drug Consumption

July 1, 2022
Deepti Anbarasan, MD and Christopher Clayton, MD, EdM

Christopher L. Clayton, MD, EdM. PGY-4 psychiatry resident, NYU Gorssman School of Medicine, New York, NY. Deepti Anbarasan, MD. Associate Professor in Psychiatry and Neurology, New York University, New York, NY.

Dr. Clayton and Dr. Anbarasan, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Supervised Consumption Sites are clinical settings where patients can use drugs in as safe a manner as possible. Clients are supplied with sterile equipment and the clinics are staffed by medical professionals who can respond in the case of an overdose. Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.


Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.